Liver Disease

Award Recipients

  • Available Programs
  • Login / Register
  • Program Overview
    • Scientific Focus
    • Scientific Review Committee
    • Eligibility
    • Criteria For Selection
  • Application Information
    • Research Proposal Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Applications
  • Award Recipients
  • Contact
Gilead Sciences Research Scholars Program in Liver Disease

2020 Recipients

Background Image

Juliet Emamaullee MD, PhD FRCSC FACS

University of Southern California

"Temporal Changes in the Immune Landscape During Liver Transplantation Rejection"

Background Image

Suraj J. Patel, MD, PhD

Beth Israel Deaconess Medical Center, Harvard Medical School

"Role of IRF3 in uncoupling hepatic metabolism in NAFLD"

Background Image

Ji-Yeon Shin, PhD

Columbia University

"A Novel Nuclear Envelope Mediator of Steatosis and NASH"

2019 Recipients

Background Image

Po-Hung Chen, MD

Johns Hopkins University

"The Impacts of Early Liver Transplantation and Sustained Abstinence on the Natural History of Severe Alcoholic Hepatitis – A Survival Benefit Study"

Background Image

Zhenghui Gordon Jiang, MD, PhD

Beth Israel Deaconess Medical Center

"Targeting Cholesterol Toxicity via Abnormal Lipoproteins in Alcoholic Hepatitis"

Background Image

Vanessa Leone, PhD

The University of Chicago

"The Role Of Diet-Induced Dysbiosis on Liver Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD): Identifying Causation And Microbiome-Based Interventional Strategies"

Background Image

Nataliya Razumilava, MD

University of Michigan

"Utility of Preclinical Organoid Models For Extrahepatic Cholangiocarcinoma Diagnosis And Treatment Assessment"

2018 Recipients

Background Image

Adam J. Gehring, PhD

Toronto Centre for Liver Disease University Health Network

"Immunological Response to HBV Reactivation in Patients Stopping Nucleoside Analogue"

Background Image

Dragana Kopanja, PhD

University of Illinois at Chicago

"Roles of FoxM1 in Hepatic Stellate Cells in Liver Fibrosis and HCC Development"

Background Image

Michelle T. Long, MD

Boston University School of Medicine

"Determining the Burden, Heritability, and Clinical Implications of Increased Liver Stiffness from Fatty Liver Disease in Older Adults"

Background Image

Ryan J. Schulze, PhD

Mayo Clinic

"A Novel Autophagic Mechanism Mediating Lipid Droplet Catabolism in Hepatocytes"

2017 Recipients

Background Image

Zongdi Feng, PhD

The Ohio State University College of Medicine

“Biogenesis and Functions of Secreted HBV RNA Particles”

Background Image

Samar Ibrahim, MB, ChB

Mayo Clinic

“Mechanisms of Liver Injury in Nonalcoholic Steatohepatitis”

Background Image

Daniela Sia, PhD

Icahn School of Medicine at Mount Sinai

“Biomarkers of Response to lmmunotherapy in Liver Cancer”

Background Image

Qian Xie, MD, PhD

James H. Quillen College of Medicine

East Tennessee State University

“Met-Targeting T Cell Therapy against Hepatocellular Carcinoma”

2016 Recipients

Background Image

Jaime Chu, MD

Icahn School of Medicine at Mount Sanai

“Protein Glycosylation as a Novel Cellular Regulator of Hepatic Fibrosis”

Background Image

Joanne Hsieh, PhD

College of Physicians and Surgeons of Columbia University

“Hepatoprotective Mechanisms in TTC39B Deficiency”

Background Image

Genta Kakiyama, PhD

Virginia Commonwealth University

“Elucidation of the Oxysterol Pathway and the Role of CYP71B in the Development of Liver Inflammation and Firbrosis”

Background Image

Harmeet Malhi, MBBS

Mayo Clinic College of Medicine

“Endoplasmic Reticulum Stress and Sphingolipids in NASH”

2015 Recipients

Background Image

Andras Heczey, MD

Baylor College of Medicine

“Immunotherapy of Hepatocellular Carcinoma with Dual Specific Natural Killer T Cells”

Background Image

Robert Christian Huebert, MD

Mayo Clinic

“Epigenetic Mechanisms of Biliary Regeneration”

Background Image

Jennifer Layden, MD, PhD

Loyola University Chicago

“HBV Genotype E: Impact on Virologic and Serologic Host Response”

Background Image

Massimiliano Paganelli, MD, PhD

CHU Sainte-Justine - Universitié de Montreal

“Autologous Transplantation of Induced Pluripotent Stem Cells-Derived Hepatocytes to Treat Hereditary Tyrosinemia Type 1”

2014 Recipients

Background Image

Matthew Burchill, PhD

University of Colorado, Denver

“Immune Reconstitution and Reversal of Chronic Exhaustion Following Novel Directly-Acting Antiviral (DAA) Therapy”

Background Image

Like Engelking, MD, PhD

UT Southwestern Medical Center

“Site-2 Protease and Fatty Liver Disease”

Background Image

William Osbourn, PhD

Johns Hopkins University

“Pharmacological Targeting of the CCR5 Signaling Pathway to Enhance Anti-Hepatitis B Virus Immune Response”

Background Image

Dean Yimlamai, MD, PhD

Boston Children's Hospital

“Novel Regulators of Hippo Signaling in Liver Disease”

2013 Recipients

Background Image

Akiko Eguchi, PhD

University of California, San Diego

“The Development of Novel Diagnostic and Therapeutic Approaches for Non-Alcoholic Liver Disease Targeting Circulating Microparticles with Specific Antigens and MicroRNA Compositions”

Background Image

Michel Fausther, PhD

University of Arkansas for Medical Sciences

“Ecto-5’-Nucleotidase/CD73 in the Pathogenesis of Liver Fibrosis”

Background Image

Guisheng Song, PhD

University of Minnesota

“MicroRNA-206 as a Therapeutic Agent for Hepatocellular Carcinoma by Inhibiting Notch3”

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved.